The global dorsomorphin dihydrochloride market is anticipated to grow at a significant CAGR during the forecast period. Dorsomorphin dihydrochloride (BML-275 dihydrochloride; Compound C dihydrochloride) is an AMPK inhibitor with a Ki of 109 nM that is potent, selective, and ATP-competitive. Dorsomorphin dihydrochloride inhibits the BMP pathway by binding to the ALK2, ALK3, and ALK6 type receptors. Autophagy is induced by dorsomorphin dihydrochloride. In vitro, it stimulates cardiomyogenesis in mouse embryonic stem cells (ESCs) as part of a chemical cocktail to promote the neuronal development of hPSCs. In cancer cell lines, it has been shown to trigger autophagy through a mechanism unrelated to AMPK inhibition.
The growing need for bioscience research is propelling the global dorsomorphin dihydrochloride market. In addition, over the next six years, the hydrochloric (HCL) acid market is predicted to be driven by rising hydrogen chloride (HCI) use in the steel and pharmaceutical industries. However, market growth is expected to be hampered by a lack of raw material availability and resulting in price variations. Furthermore, over the projected period, government laws governing chlorofluorocarbon (CFC) emissions during HCl synthesis are expected to act as a market restraint. Increased investment in the oil and gas sector, as well as the mining industry, has led to market participants conducting R&D for application development, resulting in offering an opportunity for the global dorsomorphin dihydrochloride market.
Market Coverage
o By Product Type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Market Segmentation
Global Dorsomorphin Dihydrochloride Market, By Product Type
Global Dorsomorphin Dihydrochloride Market, By Application
Global Dorsomorphin Dihydrochloride Market, By Geographic Region
North America
Europe
Asia-Pacific
Rest of the World